Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Interparfums (IPAR) Cash & Equivalents (2016 - 2025)

Interparfums (IPAR) has disclosed Cash & Equivalents for 16 consecutive years, with $158.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 26.04% to $158.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $158.1 million through Dec 2025, up 26.04% year-over-year, with the annual reading at $158.1 million for FY2025, 26.04% up from the prior year.
  • Cash & Equivalents hit $158.1 million in Q4 2025 for Interparfums, up from $110.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $159.6 billion in Q4 2021 to a low of $21.0 million in Q1 2024.
  • Historically, Cash & Equivalents has averaged $8.1 billion across 5 years, with a median of $107.4 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: soared 93966.51% in 2021 and later tumbled 99.93% in 2022.
  • Year by year, Cash & Equivalents stood at $159.6 billion in 2021, then crashed by 99.93% to $104.7 million in 2022, then fell by 15.52% to $88.5 million in 2023, then soared by 41.79% to $125.4 million in 2024, then rose by 26.04% to $158.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for IPAR at $158.1 million in Q4 2025, $110.4 million in Q3 2025, and $151.5 million in Q2 2025.